ClinicalTrials.Veeva

Menu
C

Clinical Research Specialists, LLC | Kissimmee, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BI 1015550
BI 1819479
DUPIXENT®
Buloxibutid
Nerandomilast
Olodaterol
PLN-74809
Bexotegrast
Tiotropium

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 10 total trials

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast (FIBRONEER™-ON)

This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have c...

Enrolling
Progressive Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Drug: Nerandomilast

This study is open to adults 40 years or older with idiopathic pulmonary fibrosis (IPF). People can join the study if they are not on any treatment f...

Active, not recruiting
Idiopathic Pulmonary Fibrosis
Drug: Placebo matching BI 1819479
Drug: BI 1819479

This study is open to people aged 40 years or older who have at least 1 family member with pulmonary fibrosis. Pulmonary fibrosis is a condition wher...

Begins enrollment in 3 months
Interstitial Lung Abnormalities
Interstitial Lung Diseases
Drug: Placebo
Drug: Nerandomilast

The ASPIRE trial is a 52 week randomized, double-blind, placebo-controlled, parallel-group, multicenter trial in which the efficacy, safety, and phar...

Enrolling
Idiopathic Pulmonary Fibrosis (IPF)
Drug: Placebo
Drug: Buloxibutid

Trial sponsors

Boehringer Ingelheim logo
P
Regeneron Pharmaceuticals logo
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems